Chronic non-specific neck pain. Cervicalgia
Conditions
Interventions
Intervention 1: Intervention group 1: This group receives tDCS along with mobilization of the neck joints. The tDCS treatment consists of ten 20 minute sessions over two weeks, and the mobilization tr
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age range between 18 -50. history of non-specific chronic neck pain for more than 3 months. Average pain intensity greater than or equal to 35 mm according to the visual analogue scale per week. Ability to read and write in Persian at a basic level No taking sedatives. No consumption of tea or coffee at least 10 hours prior to the electroencephalography record.
Exclusion criteria
Exclusion criteria: History of injury or surgery in the head and neck. Presence of radicular pain in the upper limb. Presence of tumor and vascular disorders. History of neurological and rheumatic diseases. Noticeable deformities in the spine such as scoliosis or kyphosis History of fibromyalgia Self-reported history of dizziness and balance disorders. History of receiving any treatment in the neck area within the past three months, History of significant cognitive or communicative disorders (scoring less than 24 on the Mini-Mental State Examination questionnaire) Unwillingness to continue participating in the study. Contraindications for using tDCS such as epilepsy, the presence of a cardiac pacemaker, a tumor, and the presence of any implant in the skull.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: The pain intensity will be measured at the beginning of the study (before the treatment starts), two weeks later (after the treatment sessions have ended), and three months after the end of treatment (follow-up). Method of measurement: The pain intensity will be measured using the Visual Analog Scale (VAS) and Short Form McGill Pain Questionnaire (SF-MPQ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Neck Disability Index. Timepoint: The neck disability will be measured at the beginning of the study (before the treatment starts), two weeks later (after the treatment sessions have ended), and three months after the end of treatment (follow-up). Method of measurement: The neck disability will be measured using the Neck Disability Index (NDI) questionnaire.;Cervical flexion and extension range of motion. Timepoint: The cervical range of motion will be measured at the beginning of the study (before the treatment starts), two weeks later (after the treatment sessions have ended), and three months after the end of treatment (follow-up). Method of measurement: The range of motion for flexion and extension will be assessed using a goniometer. Measurements in each direction will be repeated three times, and the average value will be used for analysis.;Central Sensitization. Timepoint: The central sensitization will be measured at the beginning of the study (before the treatment starts), two weeks later (after the treatment sessions have ended), and three months after the end of treatment (follow-up). Method of measurement: The central sensitization will be measured using the Central Sensitization Inventory (CSI) questionnaire.;Relative power of the frequency spectrum. Timepoint: The relative power will be measured at the beginning of the study (before the treatment starts), two weeks later (after the treatment sessions have ended), and three months after the end of treatment (follow-up). Method of measurement: The relative power will be measured using the electroencephalography and LORETA software.;Thalamocortical dysrhythmia. Timepoint: The thalamocortical dysrhythmia will be measured at the beginning of the study (before the treatment starts), two weeks later (after the treatment sessions have ended), and three months after the end of treatment (follow-up). Method of measurement: The thalamocortical dysrhythmia will be measured using the electroencephalography and LOR | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJavad Sarrafzadeh
Iran University of Medical Sciences
Outcome results
None listed